Trial Profile
A Phase 2b, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Safety and Efficacy of Rifalazil (25 Milligram) Compared With Azithromycin (1 Gram) for the Treatment of Uncomplicated Genital Chlamydia Trachomatis Infection in Women
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2015
Price :
$35
*
At a glance
- Drugs Rifalazil (Primary) ; Azithromycin
- Indications Chlamydial infections
- Focus Therapeutic Use
- Sponsors ActivBiotics
- 01 Apr 2013 Status changed from recruiting to completed as reported ClinicalTrials.gov.
- 04 Jul 2012 New trial record
- 01 Jul 2012 Status changed from not yet recruiting to recruiting as reported ClinicalTrials.gov.